Bifidobacterium breve strain N6D12 C1090

Bifidobacterium breve strain N6D12 C1090 is a Gram-positive, anaerobic bacterium commonly found in diverse habitats, including human breast milk and the gastrointestinal tracts of healthy newborns. This strain is notably a member of the infant gut microbiota, contributing to the microbial ecosystem of the infant intestine. Its presence in breast milk indicates its potential role in establishing beneficial gut flora during early development, which is crucial for the overall health and immune function of infants. As an anaerobic organism, B. breve N6D12 C1090 thrives in low-oxygen environments, which is characteristic of the gastrointestinal tract and aligns with its adaptation to colonize the human gut. The strain's ability to inhabit both breast milk and the intestines suggests a dynamic interaction between maternal and infant microbiomes, potentially influencing the infant's digestive health and immune responses. This strain's prevalence in the microbiota of healthy newborns underscores its significance in early microbial colonization and suggests that it may play a role in the development of a balanced gut microbiome. In addition, the presence of B. breve N6D12 C1090 in breast milk may provide essential prebiotics that support the growth of beneficial bacteria in infants, highlighting its importance in promoting gut health from the very beginning of life. Further research on this strain could elucidate its specific contributions to gut health and its potential applications in probiotic therapies.